Your browser doesn't support javascript.
loading
Genetic variants in components of the NALCN-UNC80-UNC79 ion channel complex cause a broad clinical phenotype (NALCN channelopathies).
Bramswig, Nuria C; Bertoli-Avella, Aida M; Albrecht, Beate; Al Aqeel, Aida I; Alhashem, Amal; Al-Sannaa, Nouriya; Bah, Maissa; Bröhl, Katharina; Depienne, Christel; Dorison, Nathalie; Doummar, Diane; Ehmke, Nadja; Elbendary, Hasnaa M; Gorokhova, Svetlana; Héron, Delphine; Horn, Denise; James, Kiely; Keren, Boris; Kuechler, Alma; Ismail, Samira; Issa, Mahmoud Y; Marey, Isabelle; Mayer, Michèle; McEvoy-Venneri, Jennifer; Megarbane, Andre; Mignot, Cyril; Mohamed, Sarar; Nava, Caroline; Philip, Nicole; Ravix, Cecile; Rolfs, Arndt; Sadek, Abdelrahim Abdrabou; Segebrecht, Lara; Stanley, Valentina; Trautman, Camille; Valence, Stephanie; Villard, Laurent; Wieland, Thomas; Engels, Hartmut; Strom, Tim M; Zaki, Maha S; Gleeson, Joseph G; Lüdecke, Hermann-Josef; Bauer, Peter; Wieczorek, Dagmar.
Afiliação
  • Bramswig NC; Institut für Humangenetik, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany. nuria.braemswig@uni-due.de.
  • Bertoli-Avella AM; CENTOGENE AG, The Rare Disease Company, Rostock, Germany.
  • Albrecht B; Institut für Humangenetik, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.
  • Al Aqeel AI; Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Alhashem A; American University of Beirut, Beirut, Lebanon.
  • Al-Sannaa N; Alfaisal University, Riyadh, Saudi Arabia.
  • Bah M; Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Bröhl K; Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Depienne C; John Hopkins Aramco Health Care, Pediatric Services, Dhahran, Saudi Arabia.
  • Dorison N; Groupe de Recherche Clinique sorbonne Université "Déficiences Intellectuelles et Autisme", Département de Génétique, Centre de Référence Déficiences Intellectuelles de Causes Rares, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France.
  • Doummar D; Internal Medicine Department, Waldkrankenhaus Evangelical Hospital, Berlin, Germany.
  • Ehmke N; Institut für Humangenetik, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.
  • Elbendary HM; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, and Inserm U 1127, and CNRS UMR 7225, and ICM, 75013, Paris, France.
  • Gorokhova S; Service de Neurochirurgie Pédiatrique, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.
  • Héron D; AP-HP, Département de neuropédiatrie, GHUEP, Hôpital Armand Trousseau, Paris, France.
  • Horn D; Institute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • James K; Berlin Institute of Health, Berlin, Germany.
  • Keren B; Human Genetics and Genome Research Division, Clinical Genetics Department, National Research Centre, Cairo, Egypt.
  • Kuechler A; Département de Génétique Médicale, APHM, CHU Timone Enfants, Marseille, France.
  • Ismail S; Aix Marseille Univ, MMG, INSERM, Marseille, France.
  • Issa MY; Groupe de Recherche Clinique sorbonne Université "Déficiences Intellectuelles et Autisme", Département de Génétique, Centre de Référence Déficiences Intellectuelles de Causes Rares, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France.
  • Marey I; Institute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Mayer M; Departments of Neurosciences and Pediatrics, Howard Hughes Medical Institute, University of California San Diego, Rady Children's Institute for Genomic Medicine, La Jolla, CA, 92093, USA.
  • McEvoy-Venneri J; Groupe de Recherche Clinique sorbonne Université "Déficiences Intellectuelles et Autisme", Département de Génétique, Centre de Référence Déficiences Intellectuelles de Causes Rares, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France.
  • Megarbane A; Institut für Humangenetik, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany.
  • Mignot C; Human Genetics and Genome Research Division, Clinical Genetics Department, National Research Centre, Cairo, Egypt.
  • Mohamed S; Human Genetics and Genome Research Division, Clinical Genetics Department, National Research Centre, Cairo, Egypt.
  • Nava C; Groupe de Recherche Clinique sorbonne Université "Déficiences Intellectuelles et Autisme", Département de Génétique, Centre de Référence Déficiences Intellectuelles de Causes Rares, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France.
  • Philip N; AP-HP, Département de neuropédiatrie, GHUEP, Hôpital Armand Trousseau, Paris, France.
  • Ravix C; Departments of Neurosciences and Pediatrics, Howard Hughes Medical Institute, University of California San Diego, Rady Children's Institute for Genomic Medicine, La Jolla, CA, 92093, USA.
  • Rolfs A; CEMEDIPP-Centre Medico Psychopedagogique, Beirut, Lebanon.
  • Sadek AA; Institut Jerome Lejeune, Paris, France.
  • Segebrecht L; Groupe de Recherche Clinique sorbonne Université "Déficiences Intellectuelles et Autisme", Département de Génétique, Centre de Référence Déficiences Intellectuelles de Causes Rares, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France.
  • Stanley V; Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Trautman C; Prince Abdullah bin Khaled Coeliac Disease Research Chair, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Valence S; Groupe de Recherche Clinique sorbonne Université "Déficiences Intellectuelles et Autisme", Département de Génétique, Centre de Référence Déficiences Intellectuelles de Causes Rares, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France.
  • Villard L; Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, and Inserm U 1127, and CNRS UMR 7225, and ICM, 75013, Paris, France.
  • Wieland T; Département de Génétique Médicale, APHM, CHU Timone Enfants, Marseille, France.
  • Engels H; Aix Marseille Univ, MMG, INSERM, Marseille, France.
  • Strom TM; Aix Marseille Univ, MMG, INSERM, Marseille, France.
  • Zaki MS; CENTOGENE AG, The Rare Disease Company, Rostock, Germany.
  • Gleeson JG; Albrecht Kossel Institute, University of Rostock, Rostock, Germany.
  • Lüdecke HJ; Pediatric Neurology Unit, Department of Pediatrics, Faculty of Medicine, Sohag University, Sohâg, Egypt.
  • Bauer P; Institute of Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Wieczorek D; Berlin Institute of Health, Berlin, Germany.
Hum Genet ; 137(9): 753-768, 2018 Sep.
Article em En | MEDLINE | ID: mdl-30167850
ABSTRACT
NALCN is a conserved cation channel, which conducts a permanent sodium leak current and regulates resting membrane potential and neuronal excitability. It is part of a large ion channel complex, the "NALCN channelosome", consisting of multiple proteins including UNC80 and UNC79. The predominant neuronal expression pattern and its function suggest an important role in neuronal function and disease. So far, biallelic NALCN and UNC80 variants have been described in a small number of individuals leading to infantile hypotonia, psychomotor retardation, and characteristic facies 1 (IHPRF1, OMIM 615419) and 2 (IHPRF2, OMIM 616801), respectively. Heterozygous de novo NALCN missense variants in the S5/S6 pore-forming segments lead to congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD, OMIM 616266) with some clinical overlap. In this study, we present detailed clinical information of 16 novel individuals with biallelic NALCN variants, 1 individual with a heterozygous de novo NALCN missense variant and an interesting clinical phenotype without contractures, and 12 individuals with biallelic UNC80 variants. We report for the first time a missense NALCN variant located in the predicted S6 pore-forming unit inherited in an autosomal-recessive manner leading to mild IHPRF1. We show evidence of clinical variability, especially among IHPRF1-affected individuals, and discuss differences between the IHPRF1- and IHPRF2 phenotypes. In summary, we provide a comprehensive overview of IHPRF1 and IHPRF2 phenotypes based on the largest cohort of individuals reported so far and provide additional insights into the clinical phenotypes of these neurodevelopmental diseases to help improve counseling of affected families.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Variação Genética / Canais de Sódio / Proteínas de Transporte / Marcadores Genéticos / Deficiências do Desenvolvimento / Canalopatias / Proteínas de Membrana Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Variação Genética / Canais de Sódio / Proteínas de Transporte / Marcadores Genéticos / Deficiências do Desenvolvimento / Canalopatias / Proteínas de Membrana Idioma: En Ano de publicação: 2018 Tipo de documento: Article